title: Epigenetic mechanisms in lupus.
abstract: OBJECTIVE
  Epigenetic mechanisms regulate gene expression, and epigenetic gene dysregulation is implicated in the pathogenesis of a growing number of disorders. Of the autoimmune diseases, epigenetic mechanisms are most clearly involved in human systemic lupus erythematosus (SLE). Herein, we summarize earlier work on epigenetic mechanisms contributing to human SLE. We first focus on the roles of DNA demethylation and DNA methyltransferase enzyme dysregulation, and we then review recent and important advances in this field.
  
  
  RESULTS
  Many advances in the past year have been made. The importance of DNA demethylation in SLE was confirmed through twin studies. New T lymphocyte immune genes that are activated by DNA demethylation, and that may participate in autoreactivity, were identified. Finally, novel mechanisms contributing to DNA demethylation in SLE were discovered.
  
  
  CONCLUSIONS
  A comprehensive understanding of the epigenetic mechanisms contributing to SLE will likely enable development of new therapeutic agents and strategies that target the dysregulated genes or correct the aberrant epigenetic modifications. Although specific agents have not yet been tested in SLE, the studies reviewed hold promise that these approaches will be useful in the treatment of human lupus.
authors.affiliation: University of Michigan, Ann Arbor Veterans Affairs Hospital, Ann Arbor, Michigan, USA.
authors.forename: Dipak R
authors.initials: DR
authors.lastname: Patel
authors.forename: Bruce C
authors.initials: BC
authors.lastname: Richardson
mesh_terms: D019175:DNA Methylation / Q000235:genetics; D044127:Epigenesis, Genetic / Q000235:genetics*; D006657:Histones / Q000235:genetics; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000235:genetics*
chemical_list: D006657:Histones
references.citation: Arthritis Rheum. 2001 Feb;44(2):397-407
references.pmid: 11229472
references.citation: Genes Immun. 2008 Jun;9(4):368-78
references.pmid: 18523434
references.citation: J Immunol. 2007 Nov 1;179(9):6352-8
references.pmid: 17947713
references.citation: Arthritis Rheum. 2002 May;46(5):1139-54
references.pmid: 12115215
references.citation: J Immunol. 2006 Jun 15;176(12):7143-7
references.pmid: 16751355
references.citation: Cell. 2007 May 18;129(4):823-37
references.pmid: 17512414
references.citation: Adv Immunol. 1985;37:269-390
references.pmid: 3890479
references.citation: J Rheumatol. 2008 May;35(5):804-10
references.pmid: 18398941
references.citation: Genome Res. 2010 Feb;20(2):170-9
references.pmid: 20028698
references.citation: Curr Opin Cell Biol. 2000 Apr;12(2):180-5
references.pmid: 10712915
references.citation: J Immunol. 2009 May 1;182(9):5623-32
references.pmid: 19380809
references.citation: Arthritis Rheum. 2004 Jun;50(6):1850-60
references.pmid: 15188362
references.citation: J Immunol. 2009 Feb 1;182(3):1500-8
references.pmid: 19155497
references.citation: Annu Rev Immunol. 2002;20:217-51
references.pmid: 11861603
references.citation: Expert Opin Biol Ther. 2005 May;5(5):683-90
references.pmid: 15934843
references.citation: Nature. 2007 Feb 8;445(7128):671-5
references.pmid: 17268471
references.citation: Cell. 1993 Jan 15;72(1):73-84
references.pmid: 8422685
references.citation: Genes Immun. 2010 Mar;11(2):124-33
references.pmid: 19710693
references.citation: J Autoimmun. 2010 Aug;35(1):58-69
references.pmid: 20223637
references.citation: Acta Biochim Pol. 2001;48(4):921-33
references.pmid: 11996003
references.citation: J Cell Sci. 2003 Jun 1;116(Pt 11):2117-24
references.pmid: 12730288
references.citation: Arthritis Rheum. 2010 May;62(5):1438-47
references.pmid: 20131288
references.citation: Cancer Res. 2002 Nov 15;62(22):6784-7
references.pmid: 12438281
references.citation: Autoimmun Rev. 2004 Nov;3(7-8):516-23
references.pmid: 15546800
references.citation: Curr Opin Genet Dev. 1999 Apr;9(2):148-51
references.pmid: 10322131
references.citation: J Immunol. 2009 Sep 1;183(5):3481-7
references.pmid: 19675166
references.citation: Arthritis Rheum. 2002 May;46(5):1282-91
references.pmid: 12115234
references.citation: Arthritis Rheum. 1990 Nov;33(11):1665-73
references.pmid: 2242063
references.citation: Lancet. 1980 May 24;1(8178):1107-9
references.pmid: 6103441
references.citation: Biochem J. 2001 Feb 1;353(Pt 3):417-39
references.pmid: 11171037
references.citation: Nat Clin Pract Rheumatol. 2007 Sep;3(9):521-7
references.pmid: 17762851
references.citation: J Immunol. 2005 May 15;174(10):6212-9
references.pmid: 15879118
references.citation: J Immunol. 1988 Apr 1;140(7):2197-200
references.pmid: 3258330
references.citation: J Clin Invest. 1996 Jun 15;97(12):2866-71
references.pmid: 8675699
references.citation: J Clin Invest. 2005 Nov;115(11):3193-204
references.pmid: 16224536
references.citation: J Genet Genomics. 2009 Feb;36(2):75-88
references.pmid: 19232306
references.citation: J Immunol. 2004 Mar 15;172(6):3652-61
references.pmid: 15004168
references.citation: Curr Mol Med. 2009 Apr;9(3):242-54
references.pmid: 19355907
references.citation: J Immunol. 1995 Mar 15;154(6):3025-35
references.pmid: 7533191
references.citation: Annu Rev Genet. 1979;13:197-233
references.pmid: 231929
references.citation: Lupus. 2008 May;17(5):394-9
references.pmid: 18490415
references.citation: Nature. 2007 May 24;447(7143):407-12
references.pmid: 17522673
references.citation: EMBO J. 1997 Apr 15;16(8):2096-107
references.pmid: 9155035